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Background: Despite the common perception that latent Cytomegalovirus (CMV) infection is usually symptom-free,
emerging epidemiological evidence suggests that it may in fact be associated with higher mortality over extended
follow-up. Mechanisms responsible for this potentially important effect are unclear. CMV infection is known to have
a large impact on the distribution of T cell phenotypes, especially the accumulation of late-stage differentiated
CD8+, as well as Vδ2- γδ T-cells, which are the main subset of γδ T-cells involved in anti-CMV immunity. Its impact
on γδ T-cells in the aging context is less well-defined.
Results: Here, we investigated a group of healthy individuals aged between 21 and 89 years, in order to correlate
the frequency and differentiation status of γδ T-cells with age. We found that these parameters were only
marginally influenced by age, but were marked in people with a latent CMV infection. Thus, we observed a
significant age-associated accumulation of late-differentiated T-cells within the Vδ2- population, but only in
CMV-seropositive donors. There was also a strong trend towards reduced frequency of early-differentiated cells
within the Vδ2- phenotype. Older people had significantly higher anti-CMV IgG titers, which in turn correlated
significantly with a lower Vδ2+/Vδ2- ratio and a shift from early- to a late-differentiated Vδ2- T-cell phenotype.
Conclusions: Our findings demonstrate a strong influence of CMV on γδ T-cells during human ageing, similar to
that observed for αβ T-cells. Differences between donors of different ages are more marked in CMV-infected
individuals. The biological implications of this potent age-associated CMV-mediated immune-modulation require
clarification.
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γδ T-cells represent a minor population of approx. 5% of
the whole T-cell population in healthy adult individuals.
The ligands recognized by the γδ receptor are yet not
fully identified, but it is known that different isotypes of
γδ T-cell receptor (TCR) recognize common stress-
induced molecules on self cells as well as structures on
the surface of pathogens. The majority of γδ T-cells is
CD4-CD8-, but a small population expresses CD8 [1]. γδ
T-cells are further grouped via their different δ-chains.
The majority (approximately 70%) of γδ T-cells in human
blood is represented by the Vδ2 receptor. The remaining* Correspondence: evelyna.derhovanessian@klinikum.uni-tuebingen.de
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distribution, and reproduction in any mediumγδ T-cells in the blood mainly express the Vδ1 receptor but
other more rare subpopulations such as Vδ3, Vδ4 or Vδ5
have also been described. Vδ2+ cells recognize nonpeptidic
phosphorylated metabolites of isoprenoid biosynthetic
pathways produced by a variety of bacteria, parasites and
some tumor cells, whereas Vδ1 T cells are activated by
stress-induced molecules such as MIC-A and MIC-B [2,3].
Several investigations into the phenotypic and functional
alterations of γδ T-cells in the human aging process have
been initiated in the last few years, some demonstrating a
decrease in γδ T-cell numbers with age, mainly due
to declining numbers of the Vδ2+ subset, with the
Vδ1 population remaining stable [4-8]. There is also one
publication demonstrating a decrease in naïve and early
differentiated cells and an increase in late differentiated γδ
T-cells in men but not in women [7]. Many similar age-Med Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Impact of CMV-serostatus on frequency and
differentiation status of γδ T-cells. The frequency of Vδ2- and
Vδ2+ γδ T-cells within total T-cells (A), CD27+CD28+ early-differentiated
(B) and CD27-CD28- late-differentiated cells (C) within Vδ2+ and
Vδ2- cells as well as the differentiation index (CD27+CD28+/CD27-CD28-)
for each subset (D) were compared between CMV-seronegative (CMV-)
and CMV-seropositive (CMV+) individuals between 21 and 89 years
of age. Each symbol represents a single donor. Horizontal bars
represent the median of the group. P values were calculated using
the Mann-Whitney U-test. Y: young 21 to 38 years, 10 female, 4 male;
O: old, 55 to 89 years, 11 female, 8 male).
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accumulation of late-differentiated CD8 T-cells, have been
attributed to a latent infection with human Cyto-
megalovirus (CMV) and not chronological age [9-11].
CMV is a ubiquitous beta-herpes virus causing mostly
asymptomatic infection in healthy individuals. After
the first infection, the virus enters cellular latency, but can
reactivate repeatedly under different conditions [12]. Both
CD4 and CD8 αβ T-cells are involved in anti-CMV im-
mune surveillance. In fact a large fraction of these cells
can be specific for this single virus [13], which can lead to
an accumulation of late-differentiated CD8 T-cells, recip-
rocated by a decrease in naïve T-cells [14]. γδ T-cells have
also been implicated in anti-CMV immunity and control
of infection [15-18] which is mediated through Vδ2- cells
(mainly Vδ1 and Vδ3 but also Vδ5 [15,18]). Accordingly,
CMV-seropositivity has been associated with higher fre-
quencies and absolute numbers of Vδ2- cells in the per-
iphery [4,17,19-21] and with a more restricted repertoire
compared to Vδ2+ cells [19].
The proportion of the population infected with CMV
increases steadily with age in Western countries with a
seroconversion rate of 1-3% per year [22] and has been
associated with higher morbidity and mortality in some
studies [23,24]. Whether a latent infection with this virus
has any impact on possible age-associated putative changes
to the phenotype of γδ T-cells, as is the case with αβ
T-cells, has not been explored before. Here, we present data
demonstrating that similar to αβ T-cells, age-associated
differences in γδ T-cell frequency and differentiation
phenotype are predominantly present in individuals with a
latent infection with CMV, but in uninfected people. Add-
itionally, we describe a negative correlation between a more
late-differentiated phenotype of Vδ2- cells and anti-CMV
IgG levels in serum, which increased significantly with age
in our study cohort.
Results
Minor impact of age on the frequency and phenotype of
γδ T-cells in the absence of CMV infection
Given the strong impact of CMV-seropositivity on
age-associated alterations observed in αβ T-cells, we sought
to determine if the same was true for γδ T-cells. For this,
individuals were grouped according to CMV-serostatus and
age, and the frequency and phenotype of γδ T-cells was
compared. In CMV-seropositive individuals we observed a
significantly lower ratio of Vδ2+/Vδ2- cells in older
individuals (Figure 1A, left-hand panel), as well as a
strong age-associated trend towards a reduction in
early-differentiated CD27+CD28+ Vδ2- T-cells (p=0.059) re-
ciprocated by a significant accumulation of CD27-CD28-
Vδ2- T-cells (p=0.0399) (Figure 1B and C, left-hand graphs).
Contrary to the Vδ2- cells, in the Vδ2+ subset, ageing was
associated with higher frequency of early-differentiated cells
Figure 2 Inter-individual comparison of the differentiation
status of Vδ2- and Vδ2+ cells in individuals stratified according
to CMV. A) frequency of early-differentiated CD27+CD28+ and
B) late-differentiated CD27-CD28- cells within the Vδ2- and Vδ2+ subsets
is shown in CMV-seronegative (left-hand panel) and CMV-seropositive
(CMV+, right-hand) donors between the age of 21 and 89. P values
were calculated using the Wilcoxon matched-pairs signed rank test.
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were absent in CMV-seronegative donors (Figure 1). Here,
we only observed a significant reduction of Vδ2- T-cells
(Figure 1A left-hand graph, p=0.0045).
CMV-seropositivity is associated with phenotypic
differences in γδ T-cells
Having established a strong impact of CMV on the
manifestation of age-associated changes in the phenotype
and frequency of γδ T-cells, we investigated the impact of a
latent infection with CMV on these parameters in young
and old CMV-seronegative and CMV-seropositive individ-
uals. We observed a significantly higher proportion of Vδ2-
cells in old CMV-seropositive donors (p=0.014, Figure 1A,
left-hand graph). Although the differentiation phenotype
of the Vδ2+ population was not associated with
CMV-seropositivity, strong correlations were observed
in the Vδ2- group. Thus, in old CMV-seropositive donors,
there was a trend toward lower proportions of early-
differentiated cells (Figure 1B, left-hand panel, p=0.0.0934).
Significantly higher proportions of late differentiated cells
were observed in both young (p=0.042) and old (p=0.0142)
CMV-seropositive donors compared to age-matched
CMV-seronegative individuals (Figure 1C, left-hand
graphs). Accordingly, the differentiation index of Vδ2-
cells (the ratio between the two early and late differentiated
phenotypes) was lower in CMV-seropositive donors
(Figure 1D, left-hand panel, p=0.0334 for the old and
p=0.0653 for the young).
Confirming our findings at the population level, we
observed a more late-differentiated phenotype of Vδ2-
T-cells compared to Vδ2+ T-cells within each individual. In
the majority of CMV-seropositive donors, the Vδ2- subset
contained a lower proportion of the early-differentiated
CD27+CD28+ phenotype (p=0.0554, Figure 2A, right-hand
panel) and a significantly higher proportion of the late-
differentiated CD27-CD28- phenotype (p=0.0042, Figure 2B,
right-hand panel) compared to the Vδ2+ subsets.
This was not observed in CMV-seronegative donors
(Figure 2, left-hand panels).
Anti CMV-IgG titers rise with age and correlate with the
differentiation status of γδ T-cells
In an attempt to elucidate the reason behind a strong
impact of CMV on age-associated differences in γδ
T-cells, we performed a correlation analysis between
age and anti-CMV IgG titers. In our cohort, increasing
age was associated with higher levels of anti-CMV IgG in
serum (r=0.5320, p=0.019). For this reason and also
considering the large heterogeneity of CMV-seropositive
donors for some of the variables shown in Figure 1, we
asked whether the level of anti-CMV IgG correlated with
particular γδ T-cell subsets and phenotypes. We found a
significant decrease in the Vδ2+/Vδ2- ratio (r=-0.5170,p=0.028) with increasing titer, whereas the latter
parameter did not correlate directly with the frequency of
cells expressing the Vδ2+ receptor or lacking it (Figure 3A).
Significant correlations were observed between the differen-
tiation status of Vδ2- T-cells and anti-CMV IgG titer: the
latter correlated negatively with the frequency of early
differentiated (r= -0.5245, p=0.0327, Figure 3B, left-hand
panel) and positively with the frequency of late differenti-
ated (r= 0.5996, p=0.0085, Figure 3C, left-hand panel) Vδ2-
T-cells. Accordingly, the differentiation index of Vδ2-
cells decreased with rising CMV-specific IgG titers
(r=-0.5912, p=0.0288). There was no correlation between
the differentiation status of Vδ2+ T-cells and CMV-specific
IgG titers (Figure 3B and C, right-hand panels).
Discussion
This study demonstrates for the first time that age-
associated differences in γδ T-cell populations are marked
only in individuals with a latent CMV infection. Several
studies have reported a decrease in the counts and
Figure 3 Correlation between CMV-specific IgG titer and the frequency and differentiation phenotype of Vδ2- and Vδ2+ γδ T-cells.
Frequency of cells lacking or expressing the Vδ2 receptor (A) as well as cells with a CD27+CD28+ B) or a CD27-CD28- phenotype C) within Vδ2-
(left-hand panel) and Vδ2+ (right-hand panel) was correlated with anti-CMV IgG levels in serum of 19 CMV-seropositive individuals between the
ages of 21 and 89. P values were calculated using the Spearman correlation test.
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to the reduction in the Vδ2+ subset [4-8]. We also
observed a trend towards age-associated reduction in the
frequency of these cells, statistically significant when
CMV-seronegative and –seropositive donors were pooled
(p=0.01, data not shown). There was also a significant
accumulation of cells with a late-differentiated phenotype
of the Vδ2- γδ T-cells with increasing age, but only in
CMV-seropositive individuals. This is consistent with CMV
as a driving force for the accumulation of late-differentiated
γδ T-cells, as is the case for CD8+ αβ T-cells [9-11]. Those
data demonstrating no impact of chronological age on
reduction of naïve and accumulation of late-differentiatedmemory CD8 T-cells in CMV-seronegative individuals,
therefore also apply to Vδ2- cells which have been impli-
cated in anti-CMV immunity in several studies [4,15-21].
Thus, the age-associated increase in the differentiation
status of these cells in the elderly might be explained by
their more frequent encounter with the virus, either due to
an earlier time of primary infection and/or more reactiva-
tion rounds of the virus, which might take place in the
elderly [25]. Since both primary infection and reactivation
are usually asymptomatic, it is not possible to determine
viral infection and reactivation history with current viro-
logical tools. However, we did observe age-associated
higher anti-CMV IgG titers in our study, possibly indicating
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an individual ages. To the best of our knowledge, this is the
first study to show an age-associated difference in the
differentiation status of Vδ2- T-cells, whereas the same
trend was not seen in Vδ2+ cells, which are not involved in
anti-CMV immunity. Two studies have reported a decrease
in the frequency of naïve-phenotype cells within the Vδ2+
subset with increasing age [4,7], although this was reported
to be limited to men in one study [7]. The discrepancy
between our finding and the published data might be
due to the overrepresentation of women in our cohort
and the use of different surface markers for phenotyping
the differentiation status.
Stratifying the donors according to CMV-serostatus
revealed significantly higher frequencies of Vδ2- T-cells
in CMV+ older individuals, in line with previously
published data indicating expansion of Vδ2- cells in
healthy carriers of the virus [17,19,20] as well as large
expansions of these cells in transplant recipients
undergoing primary infection with or reactivation of
CMV [15,17,20]. Moreover, Vδ2- cells in CMV-seropositive
individuals had a more late-differentiated phenotype
compared to CMV-seronegative individuals, in line
with previously published data [19,20], whereas the
phenotype of Vδ2+ cells was not affected by a latent
infection with CMV. Confirming these findings at the
individual level, Vδ2- cells in CMV-seropositive donors
were significantly more late-differentiated compared to
Vδ2+ cells from the same donor.
Increasing evidence suggests that not only mere
seropositivity for the virus, but the way the immune
system is affected by the virus and deals with it, may
have implications in healthy ageing and mortality
[10,26]. Accordingly, not merely the presence of a latent
infection with the virus per se, but the level of anti-CMV
IgG antibodies in serum has been shown to correlate with
all-cause mortality in some studies [27,28]. In the present
study, we observed a significant correlation between the
anti-CMV IgG titer and the differentiation status only of
Vδ2- T-cells, whereas again no correlation was observed
for the Vδ2+ subset. Although similar data are lacking on
γδ T-cells, we have previously shown that individuals with
higher anti-CMV IgG titers possess significantly higher
frequencies and absolute numbers of late-differentiated
CD4+ T-cells [29]. High levels of anti-CMV IgG antibody
might indicate more activation rounds of the virus
thus leading to a more late-differentiated phenotype
of CMV-reactive Vδ2- γδ T-cells, which may be involved
in viral control. Another possible explanation might be a
direct stimulation of Vδ2- T-cells through anti-CMV IgG
and the virus during reactivation rounds. It was elegantly
demonstrated in a recent study that late-differentiated
Vδ2- T-cells in CMV-seropositive individuals express
high levels of CD16 and can be activated by ligationof this receptor through anti-CMV IgG in the presence
of the virus [20]. Vice versa, this correlation might be
due to a helper role of γδ T-cells, similar to that of
CD4+ αβ T-cells in the induction of a humoral immune
response - γδ T-cells express essential costimulatory
molecules such as CD40L, OX40, CD70 and ICOS, when
activated in vitro [30]. Further experiments are needed to
elucidate the link between high levels of anti-CMV
IgG titers and the more late-differentiated phenotype
of γδ T-cells observed in our study.
Conclusions
The data presented here demonstrate that the strong
impact of CMV-infection on T cell phenotypes generally
attributed to chronological ageing of the immune system
is not observed exclusively in αβ T-cells, but analogously
to the greater effect on αβ CD8-vs-CD4 T-cells, is also
observed inVδ2- T-cells, in line with the involvement of
these cells in anti-CMV immunity.
Material and methods
Subjects
Experiments were conducted using blood isolated from
healthy volunteers of different ages after appropriate
signed informed consent and were approved by the
Ethics Commission (IRB protocol #20070481). The
individuals participating in this study were screened for
diseases known to alter the immune response or for
consumption of medications that could alter the immune
response. Volunteers were recruited at the University
of Miami, Miller School of Medicine. In every experi-
ment reported in the present paper, 33 healthy donors
(21 women and 12 men) between the ages of 21 and
89 years (mean age 51.5 years) were evaluated.
CMV antibody screening was performed using cobas
6000® e601 analyzer (Roche, Hitachi) with Elecsys CMV
assays (Roche Diagnostics, Mannheim, Germany): CMV
IgM (μ-capture assay, cutoff index <0.7; ≥ 1.0, reactive);
CMV IgG (cutoff < 0.5 U/ml; reactive ≥ 1..0 U/ml), and
CMV IgG avidity (< 45.0 %, low avidity; 45.0-54,9%,
grey zone; ≥55,0%, high avidity). In cases of borderline or
positive CMV IgM results a recombinant CMV IgM
immunoblot (Mikrogen, Neuried, Germany) was performed
for confirmation. To ensure that there was no acute
CMV-infection at blood donation, here we analysed only
donors who were negative for anti-CMV IGM antibody.
Flow cytometry
After thawing, cryopreserved peripheral blood mononuclear
cells (PBMCs) were first treated with human immuno-
globulin, GAMUNEX (Bayer, Leverkusen, Germany) and
ethidium monoazide bromide (EMA, MoBiTec Gmbh,
Göttingen, Germany) in order to block surface Fc receptors
and non-viable cells respectively. The cells were then
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(clone: 11F2; BD Pharmingen, Heidelberg, Germany) which
was detected via Pacific Orange-labelled Fab2’ fragment
goat anti-mouse (Live Technologies, Darmstadt, Germany).
After blocking with mouse serum (Millipore, Temecula CA,
USA), directly conjugated monoclonal antibodies CD3
Alexa Fluor 700 (clone: UCHT-1), CD8 APC-H7 (clone:
SK1), CD28 PE (clone: CD28.2) (all from BD Biosciences),
CD4 PE-Cy7 (clone: OKT4), CD27 APC (clone: 0323), and
anti-Vδ2 TCR PerCP (clone: B6) (all from BioLegend,
San Diego, USA) were added for 20 minutes on ice.
After washing twice, the cells were measured immedi-
ately on an LSR II (BD, Heidelberg). The compensa-
tion of the spectral overlap was calculated
automatically by BD FACSDiva software, based on the
measurement of single colour controls. Data were
analysed using FlowJo V 7.6.5 (Tree Star, Portland,
USA).
For the analysis, the lymphocyte population was gated
in a forward / sideways scatter plot followed by exclusion
of duplets in an FSC-height-vs. FSC-width plot. After
exclusion of EMA+ dead cells, CD4-CD8- cells were gated
within the CD3+ gate and used as starting populations to
analyse γδ T-cells, which were characterised as γδ+Vδ2+
or γδ+Vδ2-. The latter populations were further studied
for CD27 and CD28 expression to determine their
differentiation phenotype (see Additional file 1 for the
gating strategy). All parental populations <120 counts were
excluded from further analysis. Data analysis and flow
cytometry staining were performed on blinded samples.
Statistical analysis
Statistical analysis was performed using GraphPad V6
(GraphPad Software, Inc., La Jolla, USA). For comparisons
between two independent groups the Mann-Whitney U
Test was used. Correlation between two continuous
variables was analyzed using the Spearman-Person Test.
Comparisons between two variables within each individual
were performed using the Wilcoxon matched-pairs signed
rank test. P-values <0.05 were considered significant.
Additional file
Additional file 1: Gating-strategy for γδ T-cell frequency and
differentiation phenotype. Flow cytometry plots representing the
gating strategy used for characterisation of γδ T-cells and their
differentiation phenotype.
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